Acme United Corporation

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, PG has a market cap of 346B. Regarding current trading prices, ACU is priced at $42.59, while PG trades at $148.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas PG's P/E ratio is 21.94. In terms of profitability, ACU's ROE is +0.10%, compared to PG's ROE of +0.24%. Regarding short-term risk, ACU is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check PG's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, UL has a market cap of 127B. Regarding current trading prices, ACU is priced at $42.59, while UL trades at $57.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas UL's P/E ratio is 19.38. In terms of profitability, ACU's ROE is +0.10%, compared to UL's ROE of +0.36%. Regarding short-term risk, ACU is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check UL's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, CL has a market cap of 67.9B. Regarding current trading prices, ACU is priced at $42.59, while CL trades at $83.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas CL's P/E ratio is 32.18. In terms of profitability, ACU's ROE is +0.10%, compared to CL's ROE of +4.32%. Regarding short-term risk, ACU is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CL's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, KVUE has a market cap of 33.6B. Regarding current trading prices, ACU is priced at $42.59, while KVUE trades at $17.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas KVUE's P/E ratio is 22.99. In terms of profitability, ACU's ROE is +0.10%, compared to KVUE's ROE of +0.14%. Regarding short-term risk, ACU is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check KVUE's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, KMB has a market cap of 32.5B. Regarding current trading prices, ACU is priced at $42.59, while KMB trades at $97.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas KMB's P/E ratio is 20.13. In terms of profitability, ACU's ROE is +0.10%, compared to KMB's ROE of +1.55%. Regarding short-term risk, ACU is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check KMB's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, EL has a market cap of 28.1B. Regarding current trading prices, ACU is priced at $42.59, while EL trades at $76.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas EL's P/E ratio is -152.61. In terms of profitability, ACU's ROE is +0.10%, compared to EL's ROE of -0.04%. Regarding short-term risk, ACU is less volatile compared to EL. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check EL's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, CHD has a market cap of 22.5B. Regarding current trading prices, ACU is priced at $42.59, while CHD trades at $95.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas CHD's P/E ratio is 31.47. In terms of profitability, ACU's ROE is +0.10%, compared to CHD's ROE of +0.17%. Regarding short-term risk, ACU is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CHD's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, SGI has a market cap of 16.6B. Regarding current trading prices, ACU is priced at $42.59, while SGI trades at $79.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas SGI's P/E ratio is 42.97. In terms of profitability, ACU's ROE is +0.10%, compared to SGI's ROE of +0.13%. Regarding short-term risk, ACU is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SGI's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, CLX has a market cap of 11.9B. Regarding current trading prices, ACU is priced at $42.59, while CLX trades at $96.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas CLX's P/E ratio is 16.15. In terms of profitability, ACU's ROE is +0.10%, compared to CLX's ROE of +15.02%. Regarding short-term risk, ACU is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CLX's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, ACU is priced at $42.59, while NTCO trades at $6.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas NTCO's P/E ratio is -11.37. In terms of profitability, ACU's ROE is +0.10%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, ACU is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check NTCO's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, ELF has a market cap of 4B. Regarding current trading prices, ACU is priced at $42.59, while ELF trades at $63.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas ELF's P/E ratio is 37.46. In terms of profitability, ACU's ROE is +0.10%, compared to ELF's ROE of +0.11%. Regarding short-term risk, ACU is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check ELF's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, IPAR has a market cap of 2.9B. Regarding current trading prices, ACU is priced at $42.59, while IPAR trades at $91.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas IPAR's P/E ratio is 17.40. In terms of profitability, ACU's ROE is +0.10%, compared to IPAR's ROE of +0.20%. Regarding short-term risk, ACU is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check IPAR's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, COTY has a market cap of 2.1B. Regarding current trading prices, ACU is priced at $42.59, while COTY trades at $2.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas COTY's P/E ratio is -3.90. In terms of profitability, ACU's ROE is +0.10%, compared to COTY's ROE of -0.14%. Regarding short-term risk, ACU is less volatile compared to COTY. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check COTY's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, SPB has a market cap of 2B. Regarding current trading prices, ACU is priced at $42.59, while SPB trades at $83.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas SPB's P/E ratio is 19.95. In terms of profitability, ACU's ROE is +0.10%, compared to SPB's ROE of +0.06%. Regarding short-term risk, ACU is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SPB's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, NWL has a market cap of 1.8B. Regarding current trading prices, ACU is priced at $42.59, while NWL trades at $4.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas NWL's P/E ratio is -6.22. In terms of profitability, ACU's ROE is +0.10%, compared to NWL's ROE of -0.11%. Regarding short-term risk, ACU is less volatile compared to NWL. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check NWL's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, EPC has a market cap of 1.1B. Regarding current trading prices, ACU is priced at $42.59, while EPC trades at $23.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas EPC's P/E ratio is 212.91. In terms of profitability, ACU's ROE is +0.10%, compared to EPC's ROE of -0.02%. Regarding short-term risk, ACU is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check EPC's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, HELE has a market cap of 545M. Regarding current trading prices, ACU is priced at $42.59, while HELE trades at $23.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas HELE's P/E ratio is -0.60. In terms of profitability, ACU's ROE is +0.10%, compared to HELE's ROE of -0.95%. Regarding short-term risk, ACU is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check HELE's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, NUS has a market cap of 362.9M. Regarding current trading prices, ACU is priced at $42.59, while NUS trades at $7.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas NUS's P/E ratio is 2.37. In terms of profitability, ACU's ROE is +0.10%, compared to NUS's ROE of +0.20%. Regarding short-term risk, ACU is less volatile compared to NUS. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check NUS's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, EWCZ has a market cap of 318.9M. Regarding current trading prices, ACU is priced at $42.59, while EWCZ trades at $5.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, ACU's ROE is +0.10%, compared to EWCZ's ROE of +0.11%. Regarding short-term risk, ACU is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check EWCZ's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, ACU is priced at $42.59, while PTNM trades at $10.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas PTNM's P/E ratio is 346.33. In terms of profitability, ACU's ROE is +0.10%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, ACU is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check PTNM's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, SKIN has a market cap of 108.7M. Regarding current trading prices, ACU is priced at $42.59, while SKIN trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas SKIN's P/E ratio is -5.32. In terms of profitability, ACU's ROE is +0.10%, compared to SKIN's ROE of -0.15%. Regarding short-term risk, ACU is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check SKIN's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, SLSN has a market cap of 85.5M. Regarding current trading prices, ACU is priced at $42.59, while SLSN trades at $1.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas SLSN's P/E ratio is 60.50. In terms of profitability, ACU's ROE is +0.10%, compared to SLSN's ROE of +0.10%. Regarding short-term risk, ACU is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check SLSN's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, AXIL has a market cap of 46.8M. Regarding current trading prices, ACU is priced at $42.59, while AXIL trades at $6.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas AXIL's P/E ratio is 57.25. In terms of profitability, ACU's ROE is +0.10%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, ACU is more volatile compared to AXIL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check AXIL's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, GROV has a market cap of 45.6M. Regarding current trading prices, ACU is priced at $42.59, while GROV trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas GROV's P/E ratio is -3.19. In terms of profitability, ACU's ROE is +0.10%, compared to GROV's ROE of -1.16%. Regarding short-term risk, ACU is less volatile compared to GROV. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check GROV's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, UG has a market cap of 33.1M. Regarding current trading prices, ACU is priced at $42.59, while UG trades at $7.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas UG's P/E ratio is 15.65. In terms of profitability, ACU's ROE is +0.10%, compared to UG's ROE of +0.19%. Regarding short-term risk, ACU is less volatile compared to UG. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check UG's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, DSY has a market cap of 10.5M. Regarding current trading prices, ACU is priced at $42.59, while DSY trades at $2.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas DSY's P/E ratio is -0.25. In terms of profitability, ACU's ROE is +0.10%, compared to DSY's ROE of +14.77%. Regarding short-term risk, ACU is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check DSY's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, ACU is priced at $42.59, while PHH trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas PHH's P/E ratio is -0.53. In terms of profitability, ACU's ROE is +0.10%, compared to PHH's ROE of +0.38%. Regarding short-term risk, ACU is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check PHH's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, MTEX has a market cap of 9.1M. Regarding current trading prices, ACU is priced at $42.59, while MTEX trades at $4.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas MTEX's P/E ratio is -0.59. In terms of profitability, ACU's ROE is +0.10%, compared to MTEX's ROE of -3.98%. Regarding short-term risk, ACU is less volatile compared to MTEX. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check MTEX's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, ACU is priced at $42.59, while BRSH trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas BRSH's P/E ratio is -0.01. In terms of profitability, ACU's ROE is +0.10%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, ACU is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BRSH's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, RAY has a market cap of 6.9M. Regarding current trading prices, ACU is priced at $42.59, while RAY trades at $2.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas RAY's P/E ratio is 3.68. In terms of profitability, ACU's ROE is +0.10%, compared to RAY's ROE of +0.09%. Regarding short-term risk, ACU is less volatile compared to RAY. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check RAY's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, TANH has a market cap of 2.3M. Regarding current trading prices, ACU is priced at $42.59, while TANH trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas TANH's P/E ratio is -0.03. In terms of profitability, ACU's ROE is +0.10%, compared to TANH's ROE of +0.04%. Regarding short-term risk, ACU is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check TANH's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, TKLF has a market cap of 946K. Regarding current trading prices, ACU is priced at $42.59, while TKLF trades at $2.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas TKLF's P/E ratio is 2.03. In terms of profitability, ACU's ROE is +0.10%, compared to TKLF's ROE of +0.17%. Regarding short-term risk, ACU is less volatile compared to TKLF. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check TKLF's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, DSYWW has a market cap of 831.2K. Regarding current trading prices, ACU is priced at $42.59, while DSYWW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas DSYWW's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.10%, compared to DSYWW's ROE of +14.77%. Regarding short-term risk, ACU is less volatile compared to DSYWW. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check DSYWW's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, NXTS has a market cap of 283K. Regarding current trading prices, ACU is priced at $42.59, while NXTS trades at $4.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas NXTS's P/E ratio is -0.09. In terms of profitability, ACU's ROE is +0.10%, compared to NXTS's ROE of -1.14%. Regarding short-term risk, ACU is less volatile compared to NXTS. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check NXTS's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, ACU is priced at $42.59, while BRSHW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas BRSHW's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.10%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, ACU is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BRSHW's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, REV has a market cap of 0. Regarding current trading prices, ACU is priced at $42.59, while REV trades at $3.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas REV's P/E ratio is -1.19. In terms of profitability, ACU's ROE is +0.10%, compared to REV's ROE of +0.89%. Regarding short-term risk, ACU is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check REV's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, ACU is priced at $42.59, while SUMR trades at $11.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas SUMR's P/E ratio is -3.66. In terms of profitability, ACU's ROE is +0.10%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, ACU is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SUMR's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, ACU is priced at $42.59, while RDEN trades at $13.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas RDEN's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.10%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, ACU is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check RDEN's competition here

ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACU stands at 161.5M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, ACU is priced at $42.59, while GROV-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACU currently has a P/E ratio of 18.28, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.10%, compared to GROV-WT's ROE of -1.16%. Regarding short-term risk, ACU is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check GROV-WT's competition here